The Harvard Catalyst Biostatistics Program had an eventful year. The Program saw many successes in 2022, in spite of the continued challenges that we face due to COVID-19. Our biostatistician and … Continue reading “Harvard Catalyst Biostatistics Program: Year-end Update 2022”
The Harvard Catalyst Biostatistics Program organizes an annual symposium on a topic of interest to Harvard Catalyst statisticians and others in the wider Harvard community. Upcoming Biostatistics Symposia: Precision Medicine: … Continue reading “Precision Medicine: Statistical Opportunities & Challenges – 4/14”
Register at:Â https://hms.az1.qualtrics.com/jfe/form/SV_50e6MyT91mGptM9 Abstract:Â In this workshop I will provide a brief overview of group-based trajectory modeling (GBTM) with a focus on applications in medicine and epidemiology. I will then discuss more … Continue reading “Harvard Catalyst Biostatistics Short Course with Daniel Nagin – 2/12”
Via Harvard Catalyst:  Harvard Catalyst Biostatistics Program leader Garrett Fitzmaurice discusses the essential role biostatistics plays in research and the increase in demand for consultations as new COVID-19 research advances. … Continue reading “5 Questions with Garrett Fitzmaurice”
Harvard Catalyst’s Biostatistics Research Seminar November 13th 3:45-5:15pm FXB, G13 No registration required Dr. Lisa Nickerson Assistant Professor of Psychiatry, HMS; Director of Applied Neuroimaging Statistics Laboratory, McLean Hospital “Applications … Continue reading “Catalyst Biostatistics Research Seminar – 11/13”
Biostatistics Work in Progress Session October 23rd 1:00-2:00pm MGH Biostatistics Center, 50 Staniford Street, Suite 560 Douglas Hayden, Assistant Professor of Medicine at Harvard Medical School, MGH, will lead the … Continue reading “Harvard Catalyst Upcoming Events”
“Cluster Randomized Trials: Ethics, Regulations, Statistics & Design” November 3, 2016 1:00-4:00pm Bray Room, Joseph B. Martin Conference Center 77 Avenue Louis Pasteur, Boston MA Please join Harvard Catalyst for … Continue reading “Harvard Catalyst Regulatory Symposium”
